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Abstract
Background: Karyotypic integrity is essential for the successful germline transmission of alleles mutated in embryonic
stem (ES) cells. Classical methods for the identification of aneuploidy involve cytological analyses that are both time
consuming and require rare expertise to identify mouse chromosomes.
Results: As part of the International Mouse Phenotyping Consortium, we gathered data from over 1,500 ES cell clones
and found that the germline transmission (GLT) efficiency of clones is compromised when over 50 % of cells
harbour chromosome number abnormalities. In JM8 cells, chromosomes 1, 8, 11 or Y displayed copy number
variation most frequently, whilst the remainder generally remain unchanged. We developed protocols employing
droplet digital polymerase chain reaction (ddPCR) to accurately quantify the copy number of these four
chromosomes, allowing efficient triage of ES clones prior to microinjection. We verified that assessments of
aneuploidy, and thus decisions regarding the suitability of clones for microinjection, were concordant between
classical cytological and ddPCR-based methods. Finally, we improved the method to include assay multiplexing
so that two unstable chromosomes are counted simultaneously (and independently) in one reaction, to
enhance throughput and further reduce the cost.
Conclusion: We validated a PCR-based method as an alternative to classical karyotype analysis. This technique
enables laboratories that are non-specialist, or work with large numbers of clones, to precisely screen ES cells
for the most common aneuploidies prior to microinjection to ensure the highest level of germline transmission
potential. The application of this method allows early exclusion of aneuploid ES cell clones in the ES cell to
mouse conversion process, thus improving the chances of obtaining germline transmission and reducing the
number of animals used in failed microinjection attempts. This method can be applied to any other experiments that
require accurate analysis of the genome for copy number variation (CNV).
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Background
Genome sequence data and the subsequent generation
of targeted mutation libraries in mouse Embryonic
Stem (ES) cells have facilitated the systematic analysis
of gene function in mutant animal models [1]. Initial
large-scale projects created over 1,300 mouse lines,
annotated the function of over 800 mouse genes and
piloted such intricate analyses in a high-throughput
fashion [2, 3]. The remit of the International Mouse
Phenotyping Consortium (IMPC) is to capitalise fur-
ther on these resources and generate, characterise and
disseminate up to 20,000 knock-out mouse lines [4]. Both
the PHENOMIN Institut Clinique de la Souris (ICS) and
the Mary Lyon Centre (MLC) at the Medical Research
Council (MRC) Harwell are members of this worldwide
coordinated consortium. Collectively, these two centres
have so far imported and checked the karyotype of over
3,500 ES cell clones, by either cytological or ddPCR-based
methods, for the high-throughput conversion of cells into
mouse models. In this pipeline setting, the nature and
scale of which is unusual in academia, both centres
injected a large number of clones under standardised con-
ditions, including the number of embryo hosts used, and
each clone was generally not re-injected. The efficiency of
the ES cell to mouse conversion process is essential to the
success of such a programme. The consortium continually
strives for improvements in germline transmission (GLT)
efficiency, and the scale of the effort creates the opportun-
ity to thoroughly test and assess improvements to this
process. In doing so, we have developed and implemented
new protocols to aid conversion from ES cell to mouse,
one of which is described here.
Published data indicate that karyotypic instability of
modified ES cells is a major reason for the failure of
GLT [5–8]. It is widely accepted that chromosome
abnormalities are frequently found in ES cell lines
subjected to extended passages in culture [9–12].
Typically, mouse ES cell line abnormalities are a gain
of Chr 8 and/or 11, and often loss of Chr Y, but each
parental cell line may also show trends for other spe-
cific chromosomes anomalies (e.g J1 mESCs exhibit
gain of chromosome 8 and structural rearrangements/
Roberstonian translocations involving chromosome
11) [9–12]. Compound trisomy 8 and 11 can be ob-
served in mouse ES cells, and frequency increases
with passage of cells but does not seem to impact the
ability of the cells to differentiate [10]. Trisomy 8 was
shown to impact the GLT potential of ES cells [5],
supporting the notion that karyotypic changes are a
major reason for the lack of contribution from indi-
vidual ES cell clones to the germline of chimeras.
At present, although Chr 8, 11 and Y have been
highlighted as particularly unstable in cultured ES cells
[9–12], no large-scale study has been performed to
identify the chromosomes unstable at high frequency in
the cell lines employed for the generation of gene target-
ing libraries derived from the C57BL/6N genetic back-
ground. Cotton et al. [13] proposed 50 % euploidy as the
threshold at which clones are deemed acceptable for in-
jection, as the 8 clones in their study with less than 50 %
euploid cells did not yield GLT. However, no systematic
study performed on a large number of clones describes
the relationship between the percentage of aneuploid
cells present in injected clones and their ability to trans-
mit through the germline of founder animals.
Classically, analysis of Giemsa banded (G-banded) meta-
phase spreads, or other chromosome spread preparation-
based methods are employed to identify aneuploidies [14].
We have published the description of the reference
ideogram for mouse chromosomes by such methods
[15]. Detailed karyotyping methods require extensive
training and expertise which are impractical, expensive
and time consuming in a high-throughput setting [16].
Here, we present a systematic analysis of chromosome
anomalies in large cohorts of cultured ES cell clones of
C57BL/6N and other genetic backgrounds. We document
the relationship between the incidence of chromosome
anomalies and GLT capacity, confirming the 50 % thresh-
old of euploid cell contribution for efficient ES cell to
mouse conversion. We identify four principal chromo-
somes involved, either singly or in combination, in all of
the cases of aneuploidy in 138 C57BL/6N clones that we
surveyed. We extend the study to include other parental
ES cell lines and show different trends in terms of
chromosome stability. We tease out the relationship be-
tween chromosome numbers and GLT potential of clones.
Finally, we present a new, simple and affordable protocol,
based on droplet digital polymerase chain reaction
(ddPCR), which enables the rapid screening of clones
grown in a minimum of a 96-well plate format. Whilst the
protocol does not constitute a survey of the whole genome,
it is sufficient to identify the clones most likely to support
GLT and that are therefore worthy of microinjection.
Results and discussion
Chromosome number and GLT capacity
As part of the IMPC programme [4], we microinjected
large numbers of imported ES cell clones, many of them
derived from the JM8 parental line [17], into blastocysts
under standardised conditions. The aim of these micro-
injections is to create chimeric founders that will be
mated to obtain GLT of the mutation targeted in the ES
cells. Figure 1 presents the percentage of successful GLT
per ES clone in relation to the percentage of euploid
cells present. The micro-injected clones represent a large
population, unbiased for gene families or pathways tar-
geted, thus supporting the systematic analysis of the re-
lationship between GLT potential and chromosome
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number. The dataset showed that clones with lower per-
centage of euploid cells have significantly diminished
ability to contribute to the germline. The threshold at
which GLT efficiency drops from over 80 % to just over
20 % is less than 50 % euploid metaphases. This reaf-
firms the conclusion that the threshold for efficient GLT
is 50 % as proposed by Cotton and colleagues [13], and
also suggests that this threshold is not specific to our
culture conditions and processes.
Clones with less than 50 % of euploid cells, and thus
with a low GLT efficiency, represent nearly 25 % of total
clones (C57BL/6N background) that were generated
[18]. To achieve efficient ES cell to mouse conversion,
the accurate identification and removal of clones with
abnormal chromosome numbers from the pipeline is
clearly essential. If only clones with poor euploid contri-
bution are available, successful GLT is likely to require
the microinjection of larger numbers of blastocysts. Fur-
thermore, our data suggest that, should GLT fail with a
clone with a low percentage of euploid cells, sub-cloning
and selection of karyotypically normal sub-clones, using
the protocol presented here as a screening method, may
rescue these ES cell lines and allow GLT.
In order to run an efficient ES cell to mouse conver-
sion process, clones containing less than 50 % of euploid
cells should not be injected when other clones carrying
the same gene targeting event and a higher euploid com-
plement are available. We extended our analysis to more
than 1,500 different ES mutant clones of 129S2 or
C57BL/6N genetic backgrounds and showed that the
GLT capacity is directly correlated to the percentage of
euploid metaphases detected by chromosome counting
after Giemsa staining (Additional file 1: Figure S1). The
data illustrate that parental clones and genetic back-
ground influence the likelihood of microinjection yield-
ing GLT (ie. 22 % of the sub-clones of the P1 line,
isolated from embryos of the 129S1 genetic background,
with poor karyotype retain capacity to yield GLT in con-
trast with other lines isolated from more challenging gen-
etic backgrounds). However, the 50 % threshold remains
relevant to all parental ES cell lines, across the different
genetic backgrounds included in our study, to identify the
clones with higher GLT potential for microinjection.
For clones imported from large-scale collections [18],
we analyzed both quality control pass and GLT rates of
clones according to the source (listed in methods). We
found that the identity of the distributor did not influ-
ence the frequency of chromosome number variation
and/or overall GLT rates (Additional file 2: Figure S2),
suggesting that the chromosome number instability we
show here is more intrinsic to the JM8 C57BL/6N cell
line used, than a consequence of the cell culture condi-
tions applied prior to distribution.
Unstable chromosomes in cultured ES cells
Identifying which chromosomes are prone to aneuploidy
in C57BL/6N derived ES cells was integral to establish-
ing the ddPCR karyotype screen. Additional copies of
Chr 8 and/or 11, or loss of Chr Y are frequently ob-
served in mouse ES cells, however each parental cell line
may also show additional specific chromosome anomal-
ies [9–12]. Taking advantage of the very strong expertise
in mouse chromosome analysis available at MRC
Harwell (E.P.E. and C.V.B.), we were able to identify spe-
cific chromosomal anomalies by detailed karyotype ana-
lysis of metaphase spreads [15, 19]. Table 1 summarizes
the results of this comprehensive cytogenetic karyotyp-
ing screen at the MRC. These data demonstrate that
four chromosomes (1, 8, 11 and Y) show markedly
higher frequency of aneuploidy compared to the others.
The high frequency of trisomy 8 and 11 are in-keeping
with previously published studies [5, 9, 10, 12]. Over
*** 
Fig. 1 Contribution of euploid cells and GLT rate in all C57BL/6N-derived clones. Percentage of euploid metaphases observed by Giemsa staining
metaphase spread-based karyotyping was compared to germ line efficiency obtained at ICS (left axis, grey). Number of ES mutant clones tested is
indicated on the right axis (cross). Data was analysed using the Fisher Exact test and yielded a P value of 0.000806. False discovery rate (Q) calculated
by the Benjamini-Hochberg procedure was 0.003224. This showed that clones with greater than 50 % euploid representation are preferable candidates
for microinjection
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99 % of total aneuploidy events involve at least one of
these four chromosomes (1, 8, 11 and Y) in a study involv-
ing 708 clones, thus demonstrating that for JM8-derived
clones, surveying these four chromosomes is sufficient to
identify most clones with trisomies (Table 1). Large
chromosomal fusions and translocations were also de-
tected, but at much lower frequency compared to triso-
mies; 1.1 % of all clones analysed harboured translocation
events, all of which involved at least one chromosome
from the panel identified (Chr 1, 8, 11 and Y). The major-
ity of translocation events detected were not balanced
and/or coupled with additional trisomy events and, as a
result, the copy number of the chromosomes affected will
be increased and thus detectable by quantitative PCR-
based methods. This indicates that precise quantification
of gain or loss of these chromosomes should be sufficient
to evaluate GLT potential of the great majority of clones
that transit the ES cell to mouse conversion pipeline. It re-
mains noteworthy that these methods are not expected to
detect local chromosomal rearrangements that are out of
the scope of this study.
Novel rapid method for identification of aneuploid ES cell
clones
Pilot experiments to assess chromosome number were
carried out using standard Taqman® based quantitative
Polymerase Chain Reaction (qPCR) copy counting and
genomic DNA (gDNA) in crude extracts prepared from
ES cells. In our hands, this technique was unable to
evaluate with sufficient accuracy the contribution of eu-
ploid cells in cultured clones i.e. identifying clones with
<50 % trisomy requires accurate differentiation between
copy numbers of 2.4 (trisomy present in 40 % of cells)
and 2.6 (trisomy present in 60 % of cells), without large
numbers of replicates. Furthermore, this method did not
accommodate the heterogeneity of such samples, requir-
ing precise input calibration to compensate for the vari-
ability of cell growth between ES cell clones (Additional
file 3: Figure S3). This is in keeping with previous pub-
lished studies [20, 21].
ddPCR CNV experiments using two Taqman® probe-
based assays proved a more sensitive and flexible method
for evaluating chromosome copy number from ES cell-
derived gDNA [21]. The copy number of a single gene on
each aneuploidy-prone chromosome (1, 8, 11 or Y; de-
tected by a FAM™-labelled probe) was assayed relative to
that of a calibration gene (present on either Chr 10
(MRC) or Chr 17 (ICS); detected by a VIC®-labelled
probe), each shown to be generally maintained at a stable
diploid state by cytogenetic karyotype analysis. Import-
antly, the assays proved robust with a wide range of con-
centrations of gDNA input (Additional file 4: Figure S4).
Figure 2a shows an example of FACS-like plot ob-
tained when analysing ddPCR data: We designed refer-
ence assays on chromosomes that remain diploid (as
identified by our karyotyping survey). Black dots repre-
sent droplets negative for both measured and reference
chromosomes. Green dots represent droplets positive for
the assay designed against the reference chromosome
only. Blue dots represent droplets positive for the assay
designed against the measured chromosome only (e.g.
Chr8). Orange dots represent the droplets positive for
both assays. The signal obtained from the reference
chromosome is used to assess the number of genomes
in the reaction. The droplets positive for the measured
chromosome (Blue and Orange) in relation to those
positive for the reference (Green and Orange) are
employed to define the ratio between the copy numbers
of these chromosomes (see Materials and Methods).
This yields the copy number of the measured chromo-
some, as the reference chromosome is known to remain
diploid and is set at 2 (CNV2 experiment). Figure 2b
and c illustrate an example of ddPCR data obtained with
2 clones previously shown, by analysis of chromosome
spreads, to be euploid and triploid for Chr 1, 8 and 11,
respectively. Figure 2d shows respective chromosome
Table 1 Cytogenetic karyotyping analysis of clones derived of
the JM8 parental line
Number of clones (percentage
of 708 clones analysed)
≥50 % euploidy 569 (80.5 %)
<50 % euploidya 138 (19.5 %)
ES clones with Chr 1 aneuploidyb 11 (1.6 %)
ES clones with Chr 8 aneuploidyb 119 (16.8 %)
ES clones with Chr 11 aneuploidyb 38 (5.4 %)
ES clones with Chr Y aneuploidyb 36 (5.1 %)
ES clones with at least four aneuploid
chromosomes including 1, 8, 11 and Y
2 (0.3 %)
ES clones with three aneuploid
chromosomes (at least two of these
were among 1, 8, 11 and Y)
10 (1.4 %)
ES clones with two aneuploid
chromosomes (at least one of these
were among 1, 8, 11 and Y)
45 (6.4 %)
ES clones with one aneuploid
chromosome among 1, 8, 11 and Y
81 (11.4 %)
ES clone with aneuploid chromosomes
other than 1, 8, 11 or Y
1 (0.1 %)
ES clones with only aneuploid Chr 1 only 3 (0.4 %)
ES clones with only aneuploid Chr 8 only 64 (9.0 %)
ES clones with only aneuploid Chr 11 only 6 (0.8 %)
ES clones with only aneuploid Chr Y only 2 (0.3 %)
The table shows the percentage and number of clones normal or with given
aneuploidy (1, 8, 11, and Y) and summarises the cytogenetic karyotype
analysis data generated at MRC Harwell
aThose clones carrying multiple abnormalities are included in more than one
category and as such the numbers recorded in the abnormality columns may
exceed that recorded in the < 50 % euploidy category
bOnly this aneuploidy or in combination with others aneuploidies
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Fig. 2 (See legend on next page.)
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copy numbers relative to that of a calibration gene. A
range of gene assays distributed along Chr 1, 8 and 11
were tested on known samples i.e. previously analysed
by cytogenetic karyotyping, before an optimal panel was
chosen on the basis of reproducibility and compatibility
of the optimal reaction conditions between the FAM™-
and the VIC®-labelled assays and across the panel.
Figure 2e illustrates the distribution of these assays
on mouse chromosomes and the sequences of primers
and probes are presented in Additional file 5: Table S1.
As illustrated in Fig. 2d, we found that the ddPCR-
based protocol affords the sensitivity required for the
identification of clones with trisomy contribution that
impede GLT capacity. Furthermore, it accommodates the
variability of DNA samples obtained from clones that
greatly vary in cell density and the use of a time-saving
crude lysis DNA preparation method (Fig. 3), in keeping
with other applications previously developed with the
technique [21].
It is noteworthy that clones shown to be euploid by
karyotyping of metaphase spreads typically yield ddPCR
copy numbers that are lower than 2 (ranging from 1.7 to
1.9). In a similar vein, the copy numbers for the Y chromo-
some are routinely recorded ~0.5 and not 1, although
complete loss of Y is easily identifiable by a lack of ampli-
fication of FAM™-labelled targets. This is not due to poorly
adjusted assay efficiency, as this panel of assays run in the
same conditions but using DNA extracted from ear and
other biopsies typically yields a copy number of 2
(Additional file 6: Figure S5). This suggests that the
slightly lower copy number found in ES cells is represen-
tative of the overall population in culture, rather than a
reflection of the relative efficiencies of assays. Also,
chromosome spreads count chromosomes only in the
metaphase population, whereas the ddPCR surveys all the
genomes present in culture. We therefore systematically
include a euploid and a trisomic sample, characterised by
cytogenetic karyotype analysis, in each experiment that
act as calibrators. One further concern was the variability
that the un-coordinated nature of DNA replication be-
tween copy-counted loci during the G2 phase could have
been a confounding factor, however we found that the
level of variability introduced was not sufficient to cause a
discrepancy in aneuploidy calls between methodologies.
We have mixed euploid and aneuploid (Ts8, NsY) ES
cells in increasing ratios and measured Chr 8 and Chr Y
copy numbers (Additional file 7: Figure S6). Thus, we
have illustrated that the cut-off point for microinjection
(up to 50 % of euploid cells inclusive to be injected) cor-
responds to the midpoint between the values obtained
with the control DNA that we run for each experiments
(euploid and triploid clones).
Practically, several clones are often available for the
same targeting event and the clone(s) with values closest
to that obtained with the known euploid sample are se-
lected for microinjection. Clones with borderline values
i.e. close to cut-off threshold (light grey area), are less
attractive candidates for microinjection, as they are
expected to be taken over by their aneuploid sub-
population as they are cultured further.
Figure 3 summarises karyotyping processes based on
(a) karyotyping of metaphase chromosome spreads and
(b) ddPCR and shows the marked difference of timeline
between the two processes; 3 weeks and less than 1 week,
respectively, with the latter requiring less amplification
of materials in cell culture and less labour for implemen-
tation and analysis of assays. No chromosomal abnor-
malities were observed by ddPCR for 72 % of the 378
tested clones. This is in keeping with our results from
karyotyping chromosome spreads that showed that ES
cells clones with less than 50 % euploid metaphases
represented nearly 25 % of total cells clones. For the
remaining 28 % JM8-derived clones of the ddPCR study,
3, 22, 6 and 1 % of the clones show variation of Chr 1, 8,
11 and Y ratio respectively, with some clones showing
more than one aneuploidy event (Data detailed in
Additional file 5: Table SI). Again, this study corre-
lates with data obtained from karyotyping of chromo-
some spreads where Chr 8 was identified as the
major source of trisomy.
Screening strategy
We found that assays along each chromosome could
be employed interchangeably, provided that the re-
quired annealing temperatures were compatible with
that of the calibration gene assay (Additional file 8:
Figure S7, Additional file 5: Table S2). We validated
the ddPCR method by comparing karyotyped chromo-
some metaphase spreads and ddPCR data obtained
from 16 clones (some euploid and some aneuploid). This
showed excellent correlation between the outcomes of
(See figure on previous page.)
Fig. 2 Example of evaluation of copy number by ddPCR. Panel a shows an annotated example of FACS-like plot obtained with the QuantaSoft
software, version 1.2.10.0 (Bio-Rad, CA, USA) taken from a CNV2 copy counting ddPCR experiment. Panel b and c show typical results obtained
from quantifying Chr 8 in a euploid and a trisomic sample, respectively. Panel d shows copy numbers as calculated and presented in the CNV op-
tion obtained with known euploid (Normal) and trisomic for Chr 1, 8 and 11 (Trisomic) samples as external calibrators. A new sample of unknown
quality is shown to be injectable. Vertical bars are Standard Errors. Panel e presents the distribution of the marker genes and their mouse chromo-
somal location and the assays that were employed in this study (* and ** show the position on Chr 8 of Tlr3 and Gse1, respectively)
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Fig. 3 (See legend on next page.)
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these two methods as only one clone was differently
scored by the two techniques.
Although some clones trisomic for Chr 8 also carry
other chromosomal abnormalities (0.8 % clones analysed
have aberrations on Chr 8 and 1, 4.1 % have trisomies
on both Chr 8 and 11 and aneuploidy on Chr 8 coupled
with Chr Y is detected at 4.0 %), the frequencies of such
compound event suggest that these aneuploidies arise
independently (See Additional file 5: Table S3). Interest-
ingly, double trisomy of Chr 8 and 11, found at high fre-
quencies in 2 unstable cell lines by Gaztelumendi &
Nogue [10], was observed at much lower frequency in
JM8 subclones which suggests that these compound re-
arrangements are specific to the cell lines or dependent
on cell culture conditions.
These data show that for JM8 cells, determining the
copy number of Chr 8 and Y represents the most accel-
erated screen, which should detect the majority of the
aneuploidy events and enable identification of mouse
colonies where female chimeras should be bred instead
of males. Therefore, reducing the panel of assays to two
chromosomes (i.e. 8 and Y) can be sufficient.
One hundred and thirty JM8 clones with normal
karyotype by ddPCR for Chr 8 and Y were subsequently
analysed by metaphase spread-based karyotyping. We
found that only 3.8 % (5/130) would have been elimi-
nated by metaphase spread-based karyotyping. In 3 out
of these 5 clones, the anomaly was a chromosome trans-
location, which is not expected to be readily detected
with a method aimed at copy counting, as it is unlikely
to affect the overall copy numbers of genes assayed.
Translocations without accompanying chromosome
number abnormalities represent such a rare occurrence
(3/130) within our large dataset, that we elected not to
aim to identify them as part of our screen. Noticeably,
the switch to ddPCR to identify and discard aneuploid
clones from the process of ES cell to mouse conversion
was not associated with any loss of GLT efficiency in the
production pipeline of either centre.
However, when we applied the same approach to
clones obtained from two other C57BL/6N parental lines
isolated at ICS (S3 and TB1 ES, unpublished data, ICS),
we found 13.5 % (10/74) and 15.6 % (7/45) of clones
quality control passed by ddPCR still showed various
chromosomal anomalies with metaphase spread-based
karyotyping, respectively (See Additional file 5: Table S4).
We therefore recommend that ddPCR-based chromosome
counting should focus on detecting the range of chromo-
somal instabilities relevant to the parental clone and cell
culture conditions employed. It also confirms that, with
the exception of trisomy 8, the frequencies of all other
chromosomal abnormalities are specific to the parental
cell line. However, when relevant, assays developed to
count chromosomes in one particular cell line would work
in most other ES cell lines, as genomic sequences are
greatly conserved. Also, the combination of assays pre-
sented here will be relevant to the activity of many labora-
tories, as it was developed to survey JM8-derived clones
that constitute the two major publicly available condi-
tional mutant collections of the field [1].
Multiplexed ddPCR reactions for chromosome counting
In order to further lower the reagent and labour costs
associated with the quality control of ES cell chromo-
some number, we took advantage of the scope of the
ddPCR format by multiplexing two Taqman® assays la-
belled with the same fluorophore [22]. We chose the
combination of two chromosome-specific FAM™-labelled
assays multiplexed with one VIC®-labelled reference
assay, as the former type of probe yields a stronger sig-
nal at equivalent concentration. The outcome of such an
experiment can be represented in a dotplot diagram with
eight clouds, corresponding to populations of droplets in
which different combinations of assays are positive
(Fig. 4). Examples (including data obtained with a eu-
ploid external calibrator) are shown in Additional file 9:
Figure S8. We combined assays for Chr 8 and 11 in a
primary screen, thus removing most of the trisomic
clones from the process in a single well. In the second
round, Chr 1 and Y are assayed independently. Clones
with aneuploidy of Chr 1 are discarded and females
chosen for breeding among the chimeras obtained from
ES cell clones lacking Chr Y if no other suitable clone is
available. The assays currently used for Chr 1 and Y are
not compatible with multiplexed reactions because the
levels of fluorescence emitted are too similar to differen-
tiate between assays at efficient concentrations. Alterna-
tive assays will need to be identified to allow these two
(See figure on previous page.)
Fig. 3 Comparison of processes based on karyotyping of mitotic chromosome spreads and ddPCR chromosome counting. Panel a details the
method including chromosome spreads that we used for karyotyping by chromosome counting of ES cell lines. Note that the ES cell
amplification phase spans several culture passages, including intensive preparation and evaluation of samples. The overall length of the process
covered a period of 3 weeks for each sample. Panel b details the alternative process based on the novel ddPCR method introduced in this article
as implemented at MRC Harwell. Note the shortened cell culture period, less intensive wet laboratory time (PCR-based), a faster readout of copy
numbers from raw data with an overall process time of less than 1 week for each sample. For operational reasons, the ddPCR screen is
implemented at a later passage at ICS. A key aspect of the workflow is that the DNA extraction is performed from an ES cell passage number
close to that at which the cells are injected
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Fig. 4 Evaluation of copy number by multiplexed ddPCR. The figure describes the structure of a FACS-like plot obtained with multiplexed ddPCR
analysed with the QuantaSoft software, as in version 1.2.10.0 (Bio-Rad, CA, USA). a The area in blue shows the droplets positive for either or both
unstable chromosomes analysed. The area highlighted in yellow shows droplets positive for the assay of Chr 11, whilst the area shaded in pink
shows the droplets positive for the other unstable chromosome analysed (8); (b) a similar plot where each droplet populations are annotated
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chromosomes to be assayed in the same reaction. Multi-
plexed ddPCR assays are now integrated in our large-
scale screening process, as we found that they yielded
outcome comparable to those obtained with duplexed
assays (See examples in Additional file 5: Table S5 and
Additional file 9: Figure S8).
Applications beyond large-scale ES cell to mouse
conversion programme
The ddPCR method we present here can be widely
employed. Examples include the simple quality control
of wild type ES cells prior to electroporation or targeted
ES cells at a point of amplification equivalent to micro-
injection. The protocol can also be used for the rapid
screening of ES cell colonies in 96-well format, combin-
ing loss of allele assay CNV experiment following gene
targeting and an assessment of aneuploidy complement.
Additional potential applications cover the evaluation of
copy number of endogenous genes or transgenes or karyo-
type variations in any other in vitro experimental models.
Conclusions
We summarise the results of karyotype screening of over
3,500 ES cell clones, from the IMPC pipeline and add-
itional external projects at both the MRC and ICS, by
traditional or novel methodologies. We have identified the
threshold of karyotypic instability affecting GLT capacity
in the widely used C57BL/6N-derived cells and others as
50 % of a cell population, irrespective of the parental ES
cell line involved. We showed that the majority of
chromosome abnormalities found in these cells involves
Chr 1, 8 and 11 trisomies and loss of Chr Y, singly or in
combination. The data collected by the two centres dem-
onstrates that ddPCR is a rapid, simple and affordable
method to replace the more exacting metaphase spread-
based karyotyping. Contrary to metaphase spread-based
karyotyping, the ddPCR protocol is simple to set up and
can be done in medium to high-throughput with basic
molecular biology expertise. In our institutes, the
combined labour and consumable costs per sample is
approximately $30 for ddPCR karyotyping, which is
tenfold lower than metaphase spread-based karyotyp-
ing ($300 per sample). Although the equipment
needed to generate and analyse droplets is expensive,
it is of an equivalent cost to that of a camera and
analysis software used for metaphase spread-based
karyotyping. We have further optimised this method,
by validating ddPCR-based multiplexing of 3 assays
(two targets versus one reference), with crude lysis
DNA extracts from cultured cells as the template. It
has proved a suitable method for the evaluation of
the euploid complement of cultured cells and the
identification of ES cells clones with high GLT poten-
tial and can be extended to copy number of endogenous
or transgenic markers. Thus, it will reduce the number of
failed attempts to obtain genetically engineered mouse
models, reducing the number of animals used and so pro-
viding a clear ethical improvement compatible with the
3R’s (Reduction, Refinement, Replacement) principle [23].
Methods
ES cells
JM8 C57BL/6N clones were obtained from a variety of
sources including both MMRRC (https://www.mmrrc.org/)
and EuMMCR (https://www.eummcr.org/) repositories.
P1 129S1, S3 C57BL/6N, TB1 C57BL/6N and BD10
C57BL/6N parental lines were established at ICS and se-
lected for low chromosomal abnormalities frequency
and high GLT efficiency potential.
Chromosome counting following Giemsa staining
ES cells grown without feeders were treated with
0.02 μg/ml colcemide for 2 h. Cells were then trypsi-
nised, and the cell pellet was incubated in 0.56 % KCl
for 20 min in 5 % CO2 at 37 °C (hypotonic shock). Cells
were then fixed in methanol-acetic acid 3V/1V for
20 min at room temperature, then washed three times
with methanol-acetic acid and concentrated in a small
volume. Drops of cell suspension were then plated on
glass slides at 50 °C. The cells were then allowed to dry
and stained with Giemsa 4 %. 30 metaphases are ana-
lysed using Ikaros software (MetaSystems Hard & Soft-
ware, Germany). Examples of data obtained are shown
in Additional file 10: Figure S9 panels A and B.
Karyotype analysis of ES cells
Cells grown without feeders were treated with 0.02 μg/ml
colcemide for 2 h and then treated as in [19] to obtain mi-
totic chromosome spreads on glass microscope slides for
karyotyping. For identification of chromosomes, either of
the following methods was used: (a) Images of DAPI
stained mitotic chromosome spreads were captured using
a fluorescence microscope with Smartcapture 2 software
(Digital Scientific, Cambridge, UK). The DAPI staining on
the chromosomes was reversed, and enhanced by the
software to produce reversed DAPI banding (or pseudo
G-bands) that are equivalent to Giemsa stained G-bands.
This allowed comparison with the standard ideogram of
the mouse [15] to precisely determine the origin of any
aneuploidy or other chromosome anomalies identified in
each mitotic spread. Examples of data obtained are shown
in Additional file 10: Figure S9, panels C and D; or (b) G-
banded [19] chromosome mitotic spreads from approxi-
mately half of the ES cell clones were analysed using a
standard laboratory microscope for aneuploidy or other
chromosome anomalies. Initially 50 metaphase spreads
were analysed from each ES cell line. This was later
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reduced to 30 cells per cell line with no change in the ac-
curacy of results.
Microinjection and germline transmission
Targeted ES cell clones obtained from the EUCOMM and
KOMP cell repositories (EuMMCR and MMRRC) or pro-
duced in house by either MRC or ICS, were injected into
BALB/cAnN or C57BL/6J blastocysts for chimera gener-
ation. The resulting chimeras were mated to C57BL/6N
mice, and the progeny were screened to confirm GLT.
Genomic DNA lysate preparation
We prepared crude lysis extracts from cultured cells
(minimum of a 1/10th a semi-confluent well of a 6-well
plate, corresponding to less than 1 well of a 48-well
plate). Cells were scraped from the plate surface in PBS
and pelleted by centrifugation and the PBS removed.
The cell pellets were lysed in at least 30 μl of lysis buffer
(Taqman® Sample-to-SNP kit, Applied Biosystems) and
processed as per manufacturer’s instructions. Extraction
was performed at 95 °C in a thermocycler for 3 min
prior to addition of 30 μl stabilizing buffer. Samples were
stored at 4 °C for up to two weeks, and frozen if long
term storage was required. Alternatively (at ICS), follow-
ing digestion with proteinase K, the genomic DNA was
extracted with phenol/chloroform followed by ethanol-
precipitation, as described [24].
Taqman® assays
We obtained qPCR assays from Biosearch Technologies,
CA or synthesized as PrimeTime Assays by Integrated
DNA Technologies. Hydrolysis probes contained a
5’FAM™ fluorophore with either an internal ZEN and a
3-Iowa black quencher or a 3’ BHQ1 quencher. Se-
quences of primers and probes are listed in Additional
file 5: Table S1.
Droplet digital PCR reactions
For duplex reactions, when a single chromosome target
was amplified in parallel with a reference gene assay, a
copy number variation experiment with the reference
set at 2 copies (euploid, CNV2) on the Bio-Rad QX200
ddPCR system (Bio-Rad, CA) was performed. Reaction
mixtures (20 μl) contained 1 μl crude DNA lysate or
50 ng of phenol/chloroform purified genomic DNA, 1x
ddPCR Supermix for probes (Bio-Rad, CA, USA), 225
nM of each primer (two primers per assay used) and 50
nM of each probe (one VIC®-labelled probe for the refer-
ence gene assay and one FAM™-labelled for the chromo-
some target assay). These reaction mixes were loaded
either into DG8 cartridges together with 70 μl droplet
oil per sample and droplets generated using the QX100
Droplet Generator or loaded in plate format into the
Bio-Rad QX200 AutoDG and droplets generated as per
the manufacturer’s instructions. Post droplet generation,
the oil/reagent emulsion was transferred to a 96 well
semi-skirted plate (Eppendorf AG, Hamburg, Germany)
and the samples were amplified on the Bio-Rad C1000
Touch thermocycler (95 °C for 10 min, followed by
40 cycles of 94 °C for 30 s and 58 °C for 60 s, with a final
step of 98 °C for 10 min). The plate containing the drop-
let amplicons was subsequently loaded into the QX200
Droplet Reader (Bio-Rad, CA, USA). Standard reagents
and consumables supplied by Bio-Rad were used, includ-
ing cartridges and gaskets, droplet generation oil and
droplet reader oil. For multiplex reactions, the recipe
was altered to reflect the presence of another primer
pair and FAM™-labelled probe. Reaction (20 μl in
total) contained 1 μl crude DNA prep, 1x ddPCR
Supermix for probes (Bio-Rad, CA, USA), 112.5 nM
of each chromosome-specific primer (a primer pair
for Chr 8 and 11), 25 nM of each FAM™-labelled
probe, 250 nM of each reference gene primer and 50
nM of VIC®-labelled reference gene probe. Droplets
were generated as previously described and subject to
the same thermal cycling conditions before being ana-
lysed on the QX200 Droplet reader.
Analysis of ddPCR data
The QX200 Droplet Reader recorded the number of ac-
cepted droplets in which fluorescence within the drop-
let is detected (positive droplets) by either one or both
optical channels, whilst also counting the number of
droplets in which fluorescence is absent (negative drop-
lets). A minimum of 10,000 accepted droplets per sam-
ple were used for analysis. Optimised amplification of
each of the two assays produced a 2D plot of amplitude
showing four distinct groups of data points correspond-
ing to FAM™ negative/VIC® negative, FAM™ negative/
VIC® positive, FAM™ positive/VIC® negative and
FAM™ positive/VIC® positive droplets (Fig. 2a). The
number of droplets recording fluorescence for the
chromosome-specific assay was compared to the count
obtained for the reference-specific assay, known to
occur as two copies per genome. Final copy numbers
were calculated employing the manufacturer’s Quanta-
Soft Software (Bio-Rad, CA, USA) by applying Poisson
statistics to the fraction of end-point positive reactions
(18). For further confirmation of copy number calls, we
also ran a known trisomic and known normal control.
For multiplex reactions, the 2D plot now displays eight
distinct groups of data points, which correspond to the
different combinations of each assays being positive or
negative (d escribed in details in Fig. 4). As the fluores-
cence profile i.e. level of amplitude recorded is largely
unchanged for each assay when multiplexed, it is pos-
sible to determine which groups are associated with each
assay and as such it is possible to assign results to each
Codner et al. BMC Cell Biology  (2016) 17:30 Page 11 of 13
assay individually compared to the reference, whilst
running in multiplex. To assign droplets to assays,
the cross-hair or lasso tool was employed to select
specific groups of data points. However, as the soft-
ware only allows the definition of four categories of
data points, assays must be analysed iteratively. Over-
all copy numbers of both the chromosome-specific
assays compared to the reference are calculated based
on the six higher groups of the plot combined (blue
area in Fig. 4), while the copy number of Chr 11 is
calculated based on the four higher groups of the plot
combined (yellow area in Fig. 4). The copy number of
the Chr 8 is calculated by the difference of total and
Chr 11 numbers (pink area in Fig. 4). Once again, ex-
ternal calibrators, i.e. wells containing a known triso-
mic and normal control samples were included (see
examples in Additional file 9: Figure S8). Data was
exported from the Quantasoft software following each
round of analysis to give complete profile for each
sample.
Additional files
Additional file 1: Figure S1. Analysis of clones of a variety of genetic
backgrounds by chromosome counting in metaphase chromosome
spreads. Percentage of euploid metaphases observed by Giemsa staining
metaphase spread-based karyotyping was compared to germ line effi-
ciency obtained at ICS. Data for 3 different ES cells lines, (197 XG clones,
386 BD10 clones and 284 P1 clones) from the C57BL/6N or 129S1 back-
ground are presented. Analysis using the Fisher Exact test yielded P
values of 0.016083, 0.132600 and 0.117647 for XG, BD10 and P1, respect-
ively. False discovery rate calculated by the Benjamini-Hochberg proced-
ure (Q) were 0.03216, 0.1326 and 01326, respectively. This showed that
clones with greater than 50% euploid representation are preferable can-
didates for microinjection in the case of XG clones. The two other cell
lines tended towards the same conclusion, although the low number of
clones with poorer karyotype injected did not allow reaching statistical
significance. As all other data obtained in this study (and others) yielded
similar conclusions, we estimated that injecting more clones of poor
karyotype to reach higher statistical significance for these additional cell
lines would be an unethical use of animals. (PDF 123 kb)
Additional file 2: Figure S2. Quality of karyotype of JM8-derived clones
is equivalent among distributing repositories. The figure shows the per-
centages of euploid clones sourced from the two main distributors of
JM8-derived cells and GLT rate obtained with them. The numbers of
clones in each instance is shown. These numbers illustrate that materials
obtained from different distributors are of similar quality in terms of
karyotype and GLT ability. Data was analysed using the Fisher Exact test
that and showed no evidence of difference of quality between the two
distributors. (PDF 77 kb)
Additional file 3: Figure S3. Use of standard real time PCR for
chromosome counting. The figure shows copy number of Chr 8
measured by qPCR with various input quantities of genomic DNA as
template. The experiment demonstrates that although there is linearity
across the range of concentrations relevant to the DNA preparations
assayed, the assay is not sufficiently robust for the screen. Error bar
amplitude varies with gDNA input and standardizing input is challenging
due to the disparity of growth rates between ES cell clones. qPCR assays
were performed in triplicates. SEM are represented by error bars. Both
literature and our own experience concur in concluding that standard
qPCR does not allow for sufficient accuracy to reliably identify clones
worthy of microinjection. (PDF 25 kb)
Additional file 4: Figure S4. DNA input in ddPCR reaction. The figure
shows copy number of Chr 8 (crosses) and Y (squares) measured by
ddPCR with various input quantities of genomic DNA template. Vertical
bars are Standard Errors. The experiment demonstrates linearity across
the range of concentrations relevant to the DNA preparations assayed.
This is a key point for the robustness of the screen, as gDNA preparations
are challenging to standardize due to the disparity of growth rates
between ES cell clones. (PDF 26 kb)
Additional file 5: Table S1. Sequences of primers and probes
employed in this study. Table S2. Sequences of primers and probes
evaluated for setting up screening panel. Table S3. ddPCR chromosome
counting analysis of ES cells derived of the JM8 parental line. Table S4.
Karyotypic anomalies in non-JM8 derived clones. Table S5. Comparison
of ddPCR chromosome counting outcome when performed in duplex or
multiplex. (DOCX 48 kb)
Additional file 6: Figure S5. Outcome of chromosome counting by
ddPCR with genomic DNA extracted from ear biopsies. The figure shows
copy numbers obtained using the karyotype screen assay panel on DNA
extracted from euploid ES cells (C), trisomic ES cells (Ts), X0 ES cells (Ns Y)
and female mouse ear clip (E), using the same lysis method. Vertical bars
are Standard Errors. The data illustrate that the assays are able detect the
expected copy numbers on gDNA extracted from tisssues (2 Chr 1, 8 and
11) and that the number of these chromosomes is lower in genomes
extracted from tissue cultures. (PDF 63 kb)
Additional file 7: Figure S6. Cut-off value of ddPCR for detection of
aneuploidy ES cell clones. We have mixed euploid and aneuploid (Ts8,
NsY) ES cells in increasing ratios. The figure shows the ddPCR
measurements for Chr 8 (squares) and Chr Y (circles). The horizontal axis
shows the percentage of aneuploid lysate in the mix. The data illustrate
that the midpoint between the values obtained with 100% euploid and
aneuploid samples corresponds to the cut-off between population that
are or are not worth microinjecting. (PDF 30 kb)
Additional file 8: Figure S7. Outcome of copy counting by ddPCR
with assays from different locations on a chromosome. Panel A shows
the positions of Chr 8 assays within the chromosome (Primpol) and
distally (Gse1). Panel B illustrates that different assays yield lesser (Primpol)
or better (Gse1) efficiency of resolution between negative and positive
droplets with cycling conditions optimized for the internal calibrator
assay (Dot1l). Panel C shows comparable outcome with either assays:
trisomic sample (Ts8) shows high copy number while external euploid
control (C) shows copy number slightly below 2 (Vertical bars are
Standard Errors.). We therefore elected to employ the latter assay for
routine screening because of their compatibility for multiplexing
(common optimal annealing temperature and good dot cloud
resolution). (PDF 101 kb)
Additional file 9: Figure S8. Multiplex assays of a euploid and a
trisomic ES cell clone. Chr 8 and Chr 11 were assayed each in duplex
with a reference gene assay as internal calibrator (Dot1l) (A, B, G, H) or
together in multiplex with the internal calibrator (Dot1l) (C-E and I-K) in
an euploid (A-F) and a Ts8 (G-L). Vertical bars in F and L are Standard
Errors. Panels D, E, J and K show assays run in multiplex but where chan-
nels are selected so only the positive dots corresponding to one of the 2
target chromosome are counted. Blue and Orange are positive for the
considered target chromosome(s) while Black and Green are negative. Or-
ange and Green are positive for the Dot1l assay (internal calibrator), while
Blue and Black are negative. F and L show the copy numbers resulting
from these analyses, allowing the comparison of assays run in duplex and
in multiplex. When all channels are tuned so all positive droplets are
counted, the resulting copy number is the sum of the copy numbers of
Chr 8 and Chr 11. (PDF 681 kb)
Additional file 10: Figure S9. Examples of cytogenetic analysis data.
Panels A and B show micrographs obtained after Giemsa staining for
evaluation of euploidy by chromosome counting. Panels C and D
show micrographs obtained after DAPI staining for identification of
chromosomes by their banding pattern. Normal (A and C) and aneuploid
(Dup1, Ts8; B and D) clones are presented. Red arrowheads point to tandem
translocation resulting from chromosomal duplication. (PDF 96 kb)
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